南新制药
(688189)
| 流通市值：22.56亿 | | | 总市值：22.56亿 |
| 流通股本：2.74亿 | | | 总股本：2.74亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 439,384,715.69 | 550,365,903.94 | 490,270,275.37 | 389,076,108.51 |
| 应收票据及应收账款 | 79,246,358.7 | 112,999,233.88 | 196,319,324.59 | 428,454,171.37 |
| 其中：应收票据 | 1,434,788 | 376,650 | 721,754.4 | 532,310.5 |
| 应收账款 | 77,811,570.7 | 112,622,583.88 | 195,597,570.19 | 427,921,860.87 |
| 应收款项融资 | 921,367.69 | 7,291,255.42 | 3,581,332 | 928,842.83 |
| 预付款项 | 7,633,287.85 | 15,638,474.98 | 9,690,467.49 | 16,775,635.27 |
| 其他应收款合计 | 2,659,791.01 | 2,024,999.34 | 1,088,388.01 | 1,885,861.81 |
| 其中:应收利息 | 770,250 | - | - | - |
| 存货 | 55,636,697.39 | 54,225,122.03 | 61,166,785.39 | 67,051,501.23 |
| 其他流动资产 | 16,943,090.76 | 16,345,732.3 | 16,233,089.43 | 6,978,763.08 |
| 流动资产合计 | 602,425,309.09 | 758,890,721.89 | 778,349,662.28 | 911,150,884.1 |
| 非流动资产: | | | | |
| 固定资产 | 154,894,165.41 | 160,055,330.82 | 163,557,095.29 | 171,700,405.14 |
| 在建工程 | 2,463,255.51 | 372,188.67 | 353,320.75 | 592,943.39 |
| 使用权资产 | - | 187,867.46 | 387,350.15 | 479,304.2 |
| 无形资产 | 134,974,019.3 | 139,053,372.84 | 143,134,999.08 | 133,116,642.82 |
| 开发支出 | 106,823,945.22 | 91,830,077.28 | 77,368,756.53 | 74,405,714.68 |
| 商誉 | - | - | - | 10,845,017.78 |
| 长期待摊费用 | 111,434.51 | 464,526.86 | 130,459.9 | 480,909.76 |
| 递延所得税资产 | 51,190,114.43 | 51,078,733.18 | 51,165,836.25 | 60,233,757.53 |
| 其他非流动资产 | 16,742,500 | 10,205,506.93 | 7,991,010 | 5,555,385.31 |
| 非流动资产合计 | 467,199,434.38 | 453,247,604.04 | 444,088,827.95 | 457,410,080.61 |
| 资产总计 | 1,069,624,743.47 | 1,212,138,325.93 | 1,222,438,490.23 | 1,368,560,964.71 |
| 流动负债: | | | | |
| 短期借款 | 148,166,825 | 219,044,141.67 | 218,186,641.67 | 65,050,555.56 |
| 应付票据及应付账款 | 15,756,452.79 | 28,705,587.55 | 39,590,610.58 | 44,016,762.43 |
| 应付账款 | 15,756,452.79 | 28,705,587.55 | 39,590,610.58 | 44,016,762.43 |
| 合同负债 | 2,638,563.1 | 7,617,760.94 | 1,717,411.28 | 11,691,693.17 |
| 应付职工薪酬 | 11,700,779.75 | 10,141,365.4 | 10,699,517.23 | 5,135,221.93 |
| 应交税费 | 1,602,635.16 | 1,845,091.51 | 1,262,383.41 | 2,094,711.17 |
| 其他应付款合计 | 41,754,834.32 | 59,079,155.73 | 57,393,552.17 | 24,920,386.99 |
| 一年内到期的非流动负债 | - | - | 708,264.95 | 372,034.34 |
| 其他流动负债 | 11,696,742.76 | 10,833,369.72 | 10,294,252.69 | 478,875.2 |
| 流动负债合计 | 233,316,832.88 | 337,266,472.52 | 339,852,633.98 | 153,760,240.79 |
| 非流动负债: | | | | |
| 租赁负债 | - | 743,173.65 | 228,071.82 | 695,500.53 |
| 递延收益 | 2,850,000 | 2,925,000 | 3,000,000 | 3,075,000 |
| 递延所得税负债 | 946,717.87 | 999,313.31 | 1,051,908.75 | 1,373,942.26 |
| 非流动负债合计 | 3,796,717.87 | 4,667,486.96 | 4,279,980.57 | 5,144,442.79 |
| 负债合计 | 237,113,550.75 | 341,933,959.48 | 344,132,614.55 | 158,904,683.58 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 274,400,000 | 274,400,000 | 274,400,000 | 274,400,000 |
| 资本公积 | 1,175,415,514.58 | 1,175,415,514.58 | 1,175,415,514.58 | 1,175,415,514.58 |
| 减:库存股 | 11,968,285.89 | 10,000,118.23 | 10,000,118.23 | 9,998,136.25 |
| 盈余公积 | 20,100,414.53 | 20,100,414.53 | 20,100,414.53 | 20,100,414.53 |
| 未分配利润 | -563,326,005.75 | -531,351,997.27 | -523,323,689.01 | -223,635,962.53 |
| 归属于母公司股东权益合计 | 894,621,637.47 | 928,563,813.61 | 936,592,121.87 | 1,236,281,830.33 |
| 少数股东权益 | -62,110,444.75 | -58,359,447.16 | -58,286,246.19 | -26,625,549.2 |
| 股东权益合计 | 832,511,192.72 | 870,204,366.45 | 878,305,875.68 | 1,209,656,281.13 |
| 负债和股东权益合计 | 1,069,624,743.47 | 1,212,138,325.93 | 1,222,438,490.23 | 1,368,560,964.71 |
| 公告日期 | 2025-08-29 | 2025-04-30 | 2025-04-30 | 2024-10-31 |
| 审计意见(境内) | | | 标准无保留意见 | |